Kardigan Inc. logo

Kardigan Inc.

KARD | NASDAQ
Chart Builder DCF Calculator
$14.26
+$0.13 (+0.92%)
Nov 2, 2026, 3:52 PM ET · Market open
+0.92%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026
26.8
+2.5 pts
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #866/1028 (Top 84%)

Key Statistics

Market Data

Market Cap $1.27B
1D Range
13.53 14.69
52W Range
12.63 25.90

Valuation (TTM)

PE -6.60
PB 2.05
EV/EBITDA -5.23

Valuation (NTM)

Forward PE N/A
Forward PEG 0.19
Price Target $39.00
Loading financial charts...

Profile

Kardigan, Inc. is a clinical-stage precision therapeutics company, which engages in developing medicines that target the root cause of specific cardiovascular diseases where no approved treatments exi...

Sector Healthcare
Industry Biotechnology
Employees 241
IPO Date Jun 18, 2026
Fiscal Year January - December

Latest News

Kardigan Announces Appointment of Kristin Reinke to its Board of Directors

1 month ago · businesswire.com

Kardigan Announces Appointment of Kristin Reinke to its Board of Directors
Kardigan Reports Second Quarter 2026 Financial Results and Recent Business Updates

3 months ago · businesswire.com

Kardigan Reports Second Quarter 2026 Financial Results and Recent Business Updates
Kardigan Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

4 months ago · businesswire.com

Kardigan Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

Analyst Summary

# of Analysts
1
Consensus
Buy
Price Target
$40.00
Upside
+180.50%
Buy (1)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.